logo
Select company
Select metric
-275.29%Operating Cash Flow Margin
VS
Market
8
Sector
29
Industry
52
History
44
$ 10.39Close
$ 8.24 - $ 28.14 52-Week Range
Ticker Information

Ticker

NRIX

Company Name

NURIX THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NURIX THERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NRIX - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
9/30/2025$ -230.38M-275.29%$ 83.69M
6/30/2025$ -215.18M-243.46%$ 88.38M
3/31/2025$ -191.72M-339.83%$ 56.42M
12/31/2024$ -172.58M-316.38%$ 54.55M
9/30/2024$ -97.14M-172.17%$ 56.42M
6/30/2024$ -96.1M-154.25%$ 62.3M
3/31/2024$ -74.86M-92.55%$ 80.89M
12/31/2023$ -81.36M-105.69%$ 76.99M
9/30/2023$ -146.01M-212.81%$ 68.61M
6/30/2023$ -151.18M-248.11%$ 60.94M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NURIX THERAPEUTICS INC's latest trailing twelve months (TTM) OCF % stands at -0.45%.
  • Over the past 5 years, NURIX THERAPEUTICS INC's average OCF % has been -256%.
  • The median OCF % for NURIX THERAPEUTICS INC during this period was -254.57%
  • NURIX THERAPEUTICS INC reached its highest OCF % over the past 5 years at -0.45%.
  • The lowest OCF % recorded by NURIX THERAPEUTICS INC in the same timeframe -413.72%

NURIX THERAPEUTICS INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
SNDX : SYNDAX PHARMACEUTICALS INC -387.14%URGN : UROGEN PHARMA LTD -130.66%TBPH : THERAVANCE BIOPHARMA INC 317.36%KURA : KURA ONCOLOGY INC 150.08%GYRE : GYRE THERAPEUTICS INC 0.91%ZVRA : ZEVRA THERAPEUTICS INC -74.51%CRMD : CORMEDIX INC 25.08%NAGE : NIAGEN BIOSCIENCE INC 18.24%SAGE : SAGE THERAPEUTICS INC -410.94%EYPT : EYEPOINT PHARMACEUTICALS INC -367.23%

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for NURIX THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -80K ] / Revenues [ $ 17.82M ]
(=) OCF % [ -0.45% ]

NRIX - Operating Cash Flow Margin, Last 5 years

-413.72%

Minimum

Dec 31, 2022

-0.45%

Maximum

Dec 31, 2020

-256%

Average

-254.57%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.31% with a standard deviation of 21.13%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max77.08%
average14.31%
median12.65%
std21.13%